DOCSLIB.ORG

Antimicrobial Agents Produced by Streptomyces

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Antimicrobial Agents Produced by Streptomyces Understanding microbial pathogens: current knowledge and educational ideas on antimicrobial research (Enrique Torres-Hergueta and A. Méndez-Vilas, Eds.) Antimicrobial agents produced by Streptomyces Naeima M.H. Yousef* Department of Botany & Microbiology, Faculty of Science, Assiut University, 71516 Assiut, Egypt * Corresponding author: email: [email protected] Streptomyces is a genus of Gram-positive, aerobic, filamentous and non-acid-fast actinobacteria that belongs to the family streptomycetaceae and represents the largest genus of actinobacteria. It is common in various environments; soil, composts, water (rivers and marine) and plants. The genus comprises more than 600 species with validated names. The most interesting features of Streptomyces is its ability to produce bioactive secondary metabolites, such as antifungal, antibacterial, antiviral, antitumor, anti-hypertensives, immunosuppressant, and several others. The genus produces over two-thirds of the clinically useful antibiotics of natural origin related to aminoglycosides, β-lactams, macrolides and tetracyclines. The production of most antibiotics is species specific, and the species produce them to compete with other microorganisms in the same habitats. In addition, these antibiotics protect the plant against microbial pathogens. The objectives of the current review are to shed light on the genus Streptomyces; diversity, general features and the role of this genus in production of highly valuable antimicrobial agents that commonly used in treatment of some virulent pathogens. Keywords: Streptomyces; Soil; Antibiotics; Plants; Antimicrobial agents 1. Streptomyces The name Streptomyces is derived from the Greek strepto- meaning twisted, alluding to this genus' chain- like spore production; myces means filament. The genus Streptomyces belongs to the family Streptomycetaceae and it represents the largest genus of Actinomycetes [1]. Streptomyces is a Gram-positive, aerobic, non-acid-alcohol-fast actinobacteria and has genomes with high GC-content; the mol% G+C content of the DNA lies between 69 and 78 [2,3]. Species are widely distributed and abundant in soil, including composts, plants, marine water and rivers. A few species are phytopathogens; a few others are pathogenic for humans and animals. It is characterized by an extensively branched substrate mycelium and aerial hyphae, 0.5–2.0 mm diameter, rarely fragmented or have no septation [4]. At maturity, the aerial mycelium forms chains of three to several spores (Figure 1). Some members have sporangia-, pycnidial-, sclerotia-, and synnemata-like structures [5]. The spores are nonmotile, its surface may be hairy, rugose, smooth, spiny or warty [6]. Frequently, colonies initially have a smooth surface but later develop a weft of aerial mycelium that may appear floccose, granular, powdery, or velvety. Colonies are discrete and lichenoid, leathery, or butyrous. Streptomyces produce a wide range of pigments responsible for the color of the vegetative and aerial mycelia. Additionally, colored diffusible pigments may be generated [3]. Fig. 1 Cross section of Streptomyces colony. The optimal growth temperature for most species ranged between 25–35οC. However, some species can grow at temperatures within the psychrophilic and thermophilic range. The optimum pH range for growth varied between 6.5 and 8.0. The genus can produce earthy odor that results from production of volatile metabolites geosmin (literally ‘earth smell) which gives the soil its characteristic smell, and provides an indication of just how widespread these bacteria are in the soil [7]. Upon its first characterization, it was noted that S. antibioticus produces a distinct soil odor. Streptomyces are not just free-living soil bacteria, but also form symbioses with other organisms, most notably plants and invertebrates [8]. They used Streptomyces antibiotics producer to protect themselves against infection, on the other 55 Understanding microbial pathogens: current knowledge and educational ideas on antimicrobial research (Enrique Torres-Hergueta and A. Méndez-Vilas, Eds.) hand, the plant can produce exudates which allows the development of Streptomyces in the symbiosis between Streptomyces and plants. Their species may be pathogenic for humans (such as S. somaliensis and S. sudanensiscausing mycetoma), animals or plants (such as S. caviscabies, S. acidiscabies, S. turgidiscabies and S. scabies) [9]. The nutrition of Streptomyces is chemoorganotrophic with an oxidative type of metabolism. Streptomyces is catalase positive, usually degrade polymeric substrates such as casein, gelatin, hypoxanthine, and starch in addition to adenine and L-tyrosine and reduce nitrates to nitrites. Peptidoglycan is the main component of cell wall, contains major quantities of LL-diaminopimelic acid, sometimes, low amounts of meso-diaminopimelic acid are present. The lipid profile contains major amounts of saturated, iso- and anteiso-fatty acids but lacks mycolic acids. In addition, they typically possess either hexa- or octa-hydrogenated menaquinones with nine isoprene units as the predominant isoprenolog, but menaquinones with eight and ten isoprene units are also found. A complex polar lipid pattern normally contains diphosphatidylglycerol, phosphatidylethanolamine, phosphatidylinositol, and phosphatidylinositol mannosides [10]. All Streptomyces strains studied contain a large genome, typically of linear topology. The chromosomes of sequenced Streptomyces range in size from 6,283,062 bp for S. cattleya to 11,936,683 bp predicted to code for 10,023 genes in S. bingchenggensis. The S. coelicolor A3(2) genome was originally considered to be circular and representing the model Streptomycetes [11]. In addition Streptomyces can contain small, covalently closed circular (ccc) high copy- number plasmids, larger ccc low copy-number plasmids, ccc plasmids that arise by reversible site-specific recombination from the chromosome, and linear plasmids that share features of the chromosome: a centrally located origin of replication and terminal inverted repeats with bound terminal proteins to prime end patching. A property common to may be all is their self transmissibility and ability to mobilize chromosomal DNA, making them supremely important in promoting genetic exchange and Streptomyces evolution [3]. Streptomyces considered as a promising source of wide range of important enzymes, some of which are produced on an industrial scale. They could produce amylase, cellulase, protease, tyrosinase, chitinase, lipase, catalase and phosphatase [12]. They have the ability to degrade a wide range of hydrocarbons, pesticides, aliphatic and aromatic compounds [13]. They have an important ecological role in the turnover of organic material in the soil. Streptomyces act as plant growth promoting rhizobacteria (PGPR) such as S. atrovirens which produce plant growth hormone; indol acetic acid (IAA) [14]. As well as, they are enormously important to human medicine, agriculture and food production [8]. The most interesting property of Streptomyces is the ability to produce bioactive secondary metabolites, such as antibacterial, antifungal, antiviral, antitumor, antiparasitic anti-hypertensives, and immunosuppressant compounds [15]. They produce over two-thirds of the clinically useful antibiotics of natural origin (e.g., streptomycin, neomycin and chloramphenicol, etc.) [16]. The production of most antibiotics is species specific, many strains are able to produce one or more antibiotic compounds to compete with other microorganisms in the environment and protect the plant against different pathogens. Streptomyces is one of the most predominantly sources of antibiotics used in many pharmaceutical and biotechnological applications. Almost all of the bioactive compounds produced by Streptomyces are initiated during the time coinciding with the aerial hyphal formation from the substrate mycelium [5]. Streptomyces carry resistance to their own antibiotics to avoid suicide and, under selective pressure, these resistance genes can spread to other soil bacteria and to pathogenic bacteria via horizontal gene transfer [17]. The history of antibiotics, which inhibit bacterial growth, started at 1942 with the discovery of streptothricin from Streptomyces, followed by the discovery of streptomycin, after that, the scientists intensified the search for other antibiotics from the genus. The antibiotics produced by Streptomyces were classified according to chemical structure into 6 categories: aminoglycosides, beta-lactams (β-lactams), chloramphenicol, lipopeptide, macrolides and tetracyclines, some of which aminoglycosides and β-Lactams act as bactericidal agents and others (tetracyclines, chloramphenicol and macrolides) as bacteriostatic agents. 2. Aminoglycosides Aminoglycosides are class of antibiotics (contain aminosugar substructures) that possess cyclohexyl rings substituted with amine groups and linked together by glycosidic bonds. Several Streptomyces species could produce aminoglycosides antibiotics such as streptomycin (produced by S. griseus), neomycin (S. fradiae) and kanamycin (S. kanamyceticus), gentamycin (actinobacterium Micromonospora purpurea) and tobramycin (S. tenebrarius). The most common and highly important of these antibiotics are streptomycin and neomycin. They have extensive application in the treatment of numerous infectious diseases. 2.1 Streptomycin The aminoglycoside antibiotic streptomycin was first isolated in 1943, by Schatz and Waksman (Torok et al. 2009). Streptomycin was also
Load more

Recommended publications
  • Phd Thesis ZHANG Kaixi.Pdf
    This document is downloaded from DR‑NTU (https://dr.ntu.edu.sg) Nanyang Technological University, Singapore. Glycosylated cationic block co‑beta‑peptide as antimicrobial and anti‑biofilm agents against Gram‑positive bacteria Zhang, Kaixi 2019 Zhang, K. (2019). Glycosylated cationic block co‑beta‑peptide as antimicrobial and anti‑biofilm agents against Gram‑positive bacteria. Doctoral thesis, Nanyang Technological University, Singapore. https://hdl.handle.net/10356/137037 https://doi.org/10.32657/10356/137037 This work is licensed under a Creative Commons Attribution‑NonCommercial 4.0 International License (CC BY‑NC 4.0). Downloaded on 11 Oct 2021 00:27:16 SGT GLYCOSYLATED CATIONIC BLOCK CO-BETA-PEPTIDE AS ANTIMICROBIAL AND ANTI-BIOFILM AGENTS AGAINST GRAM- POSITIVE BACTERIA ZHANG KAIXI Interdisciplinary Graduate School HealthTech NTU 2019 Sample of first page in hard bound thesis I Glycosylated cationic block co-beta-peptide as antimicrobial and anti-biofilm agents against Gram-positive bacteria ZHANG KAIXI Interdisciplinary Graduate School HealthTech NTU A thesis submitted to the Nanyang Technological University in partial fulfillment of the requirement for the degree of Doctor of Philosophy 2019 i Statement of Originality I hereby certify that the work embodied in this thesis is the result of original research, is free of plagiarised materials, and has not been submitted for a higher degree to any other University or Institution. 18 Dec 2019 Date ZHANG KAIXI ii Supervisor Declaration Statement I have reviewed the content and presentation style of this thesis and declare it is free of plagiarism and of sufficient grammatical clarity to be examined. To the best of my knowledge, the research and writing are those of the candidate except as acknowledged in the Author Attribution Statement.
    [Show full text]
  • Mechanisms of Staphylococcus Aureus Persistence And
    MECHANISMS OF STAPHYLOCOCCUS AUREUS PERSISTENCE AND ERADICATION OF CHRONIC STAPHYLOCOCCAL INFECTIONS by Rebecca Yee A dissertation submitted to the Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland December, 2018 ABSTRACT Bacteria can exist in different phenotypic states depending on environmental conditions. Under stressed conditions, such as antibiotic exposure, bacteria can develop into persister cells that allow them to stay dormant until the stress is removed, when they can revert back to a growing state. The interconversion of non-growing persister cells and actively growing cells is the underlying basis of relapsing and chronic persistent infections. Eradication and better treatment of chronic, persistent infections caused by Staphylococcus aureus requires a multi- faceted approach, including a deeper understanding of how the bacteria persist under stressed conditions, regulate its cell death pathways, and development of novel drug therapies. Persisters were first discovered in the 1940s in a staphylococcal culture in which penicillin failed to kill a small subpopulation of the cells. Despite the discovery many decades ago, the specific mechanisms of Staphylococcus aureus persistence is largely unknown. Recently renewed interest has emerged due to the rise of chronic infections caused by pathogens such as M. tuberculosis, B. burgdorferi, S. aureus, P. aeruginosa, and E. coli. Treatments for chronic infections are lacking and antibiotic resistance is becoming a bigger issue. The goal of our research is to define the mechanisms involved in S. aureus persistence and cell death to improve our knowledge of genes and molecular pathways that can be used as targets for drugs to eradicate chronic infections.
    [Show full text]
  • Genomic and Phylogenomic Insights Into the Family Streptomycetaceae Lead to Proposal of Charcoactinosporaceae Fam. Nov. and 8 No
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.08.193797; this version posted July 8, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Genomic and phylogenomic insights into the family Streptomycetaceae 2 lead to proposal of Charcoactinosporaceae fam. nov. and 8 novel genera 3 with emended descriptions of Streptomyces calvus 4 Munusamy Madhaiyan1, †, * Venkatakrishnan Sivaraj Saravanan2, † Wah-Seng See-Too3, † 5 1Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, 6 Singapore 117604; 2Department of Microbiology, Indira Gandhi College of Arts and Science, 7 Kathirkamam 605009, Pondicherry, India; 3Division of Genetics and Molecular Biology, 8 Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, 9 Malaysia 10 *Corresponding author: Temasek Life Sciences Laboratory, 1 Research Link, National 11 University of Singapore, Singapore 117604; E-mail: [email protected] 12 †All these authors have contributed equally to this work 13 Abstract 14 Streptomycetaceae is one of the oldest families within phylum Actinobacteria and it is large and 15 diverse in terms of number of described taxa. The members of the family are known for their 16 ability to produce medically important secondary metabolites and antibiotics. In this study, 17 strains showing low 16S rRNA gene similarity (<97.3 %) with other members of 18 Streptomycetaceae were identified and subjected to phylogenomic analysis using 33 orthologous 19 gene clusters (OGC) for accurate taxonomic reassignment resulted in identification of eight 20 distinct and deeply branching clades, further average amino acid identity (AAI) analysis showed 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.08.193797; this version posted July 8, 2020.
    [Show full text]
  • Induction of Secondary Metabolism Across Actinobacterial Genera
    Induction of secondary metabolism across actinobacterial genera A thesis submitted for the award Doctor of Philosophy at Flinders University of South Australia Rio Risandiansyah Department of Medical Biotechnology Faculty of Medicine, Nursing and Health Sciences Flinders University 2016 TABLE OF CONTENTS TABLE OF CONTENTS ............................................................................................ ii TABLE OF FIGURES ............................................................................................. viii LIST OF TABLES .................................................................................................... xii SUMMARY ......................................................................................................... xiii DECLARATION ...................................................................................................... xv ACKNOWLEDGEMENTS ...................................................................................... xvi Chapter 1. Literature review ................................................................................. 1 1.1 Actinobacteria as a source of novel bioactive compounds ......................... 1 1.1.1 Natural product discovery from actinobacteria .................................... 1 1.1.2 The need for new antibiotics ............................................................... 3 1.1.3 Secondary metabolite biosynthetic pathways in actinobacteria ........... 4 1.1.4 Streptomyces genetic potential: cryptic/silent genes ..........................
    [Show full text]
  • Biographical Sketch Format Page
    OMB No. 0925-0001 and 0925-0002 (Rev. 11/16 Approved Through 10/31/2018) BIOGRAPHICAL SKETCH Provide the following information for the Senior/key personnel and other significant contributors. Follow this format for each person. DO NOT EXCEED FIVE PAGES. NAME: DICK, Thomas eRA COMMONS USER NAME: TDICK367 POSITION TITLE: Member, Centre for Discovery and Innovation, Hackensack Meridian Health. EDUCATION/TRAINING Completion DEGREE FIELD OF STUDY INSTITUTION AND LOCATION Date University of Heidelberg, Germany MSc 08/1987 Biology University of Heidelberg, Germany PhD 08/1990 Bacteriology Institute of Molecular and Cell Biology, Singapore Postdoc 08/1996 Developmental biology A. Personal Statement I have 20 years of experience in antibacterial drug discovery and R&D program management. Prior to my current appointment as Member at the Center for Discovery and Innovation, Hackensack Meridian Health (CDI-HMH), I was Tuberculosis (TB) disease area head at Novartis and served as professor at the National University of Singapore and at Rutgers, Newark. My research focuses on the discovery of new medicines for the treatment of TB and lung disease caused by Non-Tuberculous Mycobacteria (NTM). At CDI-HMH I i) established a fully enabled drug discovery platform, and ii) developed an attractive portfolio of repositioning and de novo drug discovery projects with partners from industry and academia. Publications on antibiotic resistance and discovery: >100; h-index = 43. B. Positions and Honors Positions and Employment 1996-2003 Head, Mycobacterium Biology
    [Show full text]
  • Antimicrobial Activity of Actinomycetes and Characterization of Actinomycin-Producing Strain KRG-1 Isolated from Karoo, South Africa
    Brazilian Journal of Pharmaceutical Sciences Article http://dx.doi.org/10.1590/s2175-97902019000217249 Antimicrobial activity of actinomycetes and characterization of actinomycin-producing strain KRG-1 isolated from Karoo, South Africa Ivana Charousová 1,2*, Juraj Medo2, Lukáš Hleba2, Miroslava Císarová3, Soňa Javoreková2 1 Apha medical s.r.o., Clinical Microbiology Laboratory, Slovak Republic, 2 Slovak University of Agriculture in Nitra, Faculty of Biotechnology and Food Sciences, Department of Microbiology, Slovak Republic, 3 University of SS. Cyril and Methodius in Trnava, Faculty of Natural Sciences, Department of Biology, Slovak Republic In the present study we reported the antimicrobial activity of actinomycetes isolated from aridic soil sample collected in Karoo, South Africa. Eighty-six actinomycete strains were isolated and purified, out of them thirty-four morphologically different strains were tested for antimicrobial activity. Among 35 isolates, 10 (28.57%) showed both antibacterial and antifungal activity. The ethyl acetate extract of strain KRG-1 showed the strongest antimicrobial activity and therefore was selected for further investigation. The almost complete nucleotide sequence of the 16S rRNA gene as well as distinctive matrix-assisted laser desorption/ionization-time-of-flight/mass spectrometry (MALDI-TOF/MS) profile of whole-cell proteins acquired for strain KRG-1 led to the identification ofStreptomyces antibioticus KRG-1 (GenBank accession number: KX827270). The ethyl acetate extract of KRG-1 was fractionated by HPLC method against the most suppressed bacterium Staphylococcus aureus (Newman). LC//MS analysis led to the identification of the active peak that exhibited UV-VIS maxima at 442 nm and the ESI-HRMS spectrum + + showing the prominent ion clusters for [M-H2O+H] at m/z 635.3109 and for [M+Na] at m/z 1269.6148.
    [Show full text]
  • Design and Synthesis of Metallo-Β-Lactamase Inhibitors
    Design and synthesis of metallo-β-lactamase inhibitors Ricky Michael Cain Submitted in accordance with the requirements for the degree of Doctor of Philosophy The University of Leeds School of Chemistry July 2015 - ii - The candidate confirms that the work submitted is his own, except where work which has formed part of jointly-authored publications has been included. The contribution of the candidate and the other authors to this work has been explicitly indicated below. The candidate confirms that appropriate credit has been given within the thesis where reference has been made to the work of others. Chapter 4 contains work described in the publication ‘Applications of structure-based design to antibacterial drug discovery’, as published in the journal, Bio-organic Chemistry. The candidate carried out the literature review and manuscript preparation with S. Narramore. The candidate also conducted all work relating to metallo-β-lactamase inhibitor discovery. M. McPhillie and K. Simmons provided information on triclosan derivative and DHODH respectively, and C. Fishwick helped with manuscript preparation. Chapter 8 contains work described in the publication ‘Assay Platform for Clinically Relevant Metallo-β-lactamases’, as published in the journal, Journal of Medicinal Chemistry. The candidate contributed in silico studies, S. van Berkel, J. Brem and A. Rydzik carried out biological evaluation, R.Salimraj, A. Verma and R. Owens expressed the relevant proteins., and C. Fishwick, J. Spencer and C. Schofield prepared the manuscript. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. The right of Ricky Michael Cain to be identified as Author of this work has been asserted by him in accordance with the Copyright, Designs and Patents Act 1988.
    [Show full text]
  • Bactericidal Activity of Alpha-Bromocinnamaldehyde
    RESEARCH ARTICLE Bactericidal activity of alpha- bromocinnamaldehyde against persisters in Escherichia coli Qingshan Shen1☯, Wei Zhou1☯, Liangbin Hu1*, Yonghua Qi2, Hongmei Ning2, Jian Chen3, Haizhen Mo1* 1 Department of Food Science, Henan Institute of Science and Technology, Xinxiang, China, 2 Department of Animal Science, Henan Institute of Science and Technology, Xinxiang, China, 3 Institute of Food Quality and Safety, Jiangsu Academy of Agricultural Science, Nanjing, China a1111111111 ☯ These authors contributed equally to this work. a1111111111 * [email protected] (LH); [email protected] (HM) a1111111111 a1111111111 a1111111111 Abstract Persisters are tolerant to multiple antibiotics, and widely distributed in bacteria, fungi, para- sites, and even cancerous human cell populations, leading to recurrent infections and OPEN ACCESS relapse after therapy. In this study, we investigated the potential of cinnamaldehyde and its Citation: Shen Q, Zhou W, Hu L, Qi Y, Ning H, derivatives to eradicate persisters in Escherichia coli. The results showed that 200 μg/ml of Chen J, et al. (2017) Bactericidal activity of alpha- alpha-bromocinnamaldehyde (Br-CA) was capable of killing all E. coli cells during the expo- bromocinnamaldehyde against persisters in nential phase. Considering the heterogeneous nature of persisters, multiple types of persist- Escherichia coli. PLoS ONE 12(7): e0182122. ers were induced and exposed to Br-CA. Our results indicated that no cells in the ppGpp- https://doi.org/10.1371/journal.pone.0182122 overproducing strain or TisB-overexpressing strain survived the treatment of Br-CA Editor: Christophe Beloin, Institut Pasteur, FRANCE although considerable amounts of persisters to ampicillin (Amp) and ciprofloxacin (Cip) Received: January 14, 2017 were induced.
    [Show full text]
  • Protective Streptomyces in Beewolves
    Protective Streptomyces in beewolves - Ecology, evolutionary history and specificity of symbiont-mediated defense in Philanthini wasps (Hymenoptera, Crabronidae) - Dissertation zur Erlangung des akademischen Grades „doctor rerum naturalium“ (Dr. rer. nat.) vorgelegt dem Rat der Biologisch-Pharmazeutischen Fakultät der Friedrich-Schiller-Universität Jena von Dipl.-Biol. Sabrina Koehler geboren am 07.11.1982 in Zwickau Protective Streptomyces in beewolves - Ecology, evolutionary history and specificity of symbiont-mediated defense in Philanthini wasps (Hymenoptera, Crabronidae) - Seit 1558 Dissertation zur Erlangung des akademischen Grades „doctor rerum naturalium“ (Dr. rer. nat.) vorgelegt dem Rat der Biologisch-Pharmazeutischen Fakultät der Friedrich-Schiller-Universität Jena von Dipl.-Biol. Sabrina Koehler geboren am 07.11.1982 in Zwickau Das Promotionsgesuch wurde eingereicht und bewilligt am: 14. Oktober 2013 Gutachter: 1) Dr. Martin Kaltenpoth, Max-Planck-Institut für Chemische Ökologie, Jena 2) Prof. Dr. Erika Kothe, Friedrich-Schiller-Universität, Jena 3) Prof. Dr. Cameron Currie, University of Wisconsin-Madison, USA Das Promotionskolloquium wurde abgelegt am: 03.März 2014 “There is nothing like looking, if you want to find something. You certainly usually find something, if you look, but it is not always quite the something you were after.” The Hobbit, J.R.R. Tolkien “We are symbionts on a symbiotic planet, and if we care to, we can find symbiosis everywhere.” Symbiotic Planet, Lynn Margulis CONTENTS LIST OF PUBLICATIONS ........................................................................................
    [Show full text]
  • Exploration of Chemical Interactions Between Streptomyces and Eukaryotes
    i Exploration of chemical interactions between Streptomyces and eukaryotes By Louis K. Ho A thesis submitted in conformity with the requirements For the degree of Doctor of Philosophy Department of Biochemistry University of Toronto © Copyright by Louis K. Ho 2020 i Exploration of chemical interactions between Streptomyces and eukaryotes Louis K. Ho Doctor of Philosophy Department of Biochemistry University of Toronto 2020 Abstract In the environment, bacteria live in complex communities with other organisms. In this work, I characterize two new chemically-mediated ways in which bacteria and eukaryotes interact. First, I show that ingestion of Streptomyces bacteria can directly be lethal to fruit flies and that this toxicity is the result of bacterial production of insecticides. I also show that this toxicity is facilitated by airborne odors that reducesin insect progeny. Second, I show that the yeast Saccaromyces cerevisiae can trigger Streptomyces to enter a new mode of growth called ‘exploration’. I characterize ‘exploratory’ growth and identify how it is triggered by airborne chemicals and the chemical modification of the growth environment. Overall, this thesis describes two new ways in which bacteria and eukaryotes interact and highlights how chemicals play an important role in these interactions. ii ii Acknowledgements I would like to thank all past and present members of the laboratory for their support and putting up with me throughout the years. You are not only my trusted colleagues but also my friends that I hope to cherish and keep in touch with for many years to come*. I would like to thank my supervisor, Dr. Justin Nodwell for putting insurmountable faith in me from the very beginning and for shaping my view of the world.
    [Show full text]
  • Characterization of Streptomyces Species Causing Common Scab Disease in Newfoundland Agriculture Research Initiative Project
    Dawn Bignell Memorial University [email protected] Characterization of Streptomyces species causing common scab disease in Newfoundland Agriculture Research Initiative Project #ARI-1314-005 FINAL REPORT Submitted by Dr. Dawn R. D. Bignell March 31, 2014 Page 1 of 34 Dawn Bignell Memorial University [email protected] Executive Summary Potato common scab is an important disease in Newfoundland and Labrador and is characterized by the presence of unsightly lesions on the potato tuber surface. Such lesions reduce the quality and market value of both fresh market and seed potatoes and lead to significant economic losses to potato growers. Currently, there are no control strategies available to farmers that can consistently and effectively manage scab disease. Common scab is caused by different Streptomyces bacteria that are naturally present in the soil. Most of these organisms are known to produce a plant toxin called thaxtomin A, which contributes to disease development. Among the new scab control strategies that are currently being proposed are those aimed at reducing or eliminating the production of thaxtomin A by these bacteria in soils. However, such strategies require a thorough knowledge of the types of pathogenic Streptomyces bacteria that are prevalent in the soil and whether such pathogens have the ability to produce this toxic metabolite. Currently, no such information exists for the scab-causing pathogens that are present in the soils of Newfoundland. This project entitled “Characterization of Streptomyces species causing common scab disease in Newfoundland” is the first study that provides information on the types of pathogenic Streptomyces species that are present in the province and the virulence factors that are used by these microbes to induce the scab disease symptoms.
    [Show full text]
  • Redalyc.Antibacterial and Cytotoxic Bioactivity of Marine Actinobacteria
    Hidrobiológica ISSN: 0188-8897 [email protected] Universidad Autónoma Metropolitana Unidad Iztapalapa México Cardoso-Martínez, Faviola; Becerril-Espinosa, Amayaly; Barrila-Ortíz, Celso; Torres- Beltrán, Mónica; Ocampo-Alvarez, Héctor; Iñiguez-Martínez, Ana M.; Soria-Mercado, Irma E. Antibacterial and cytotoxic bioactivity of marine Actinobacteria from Loreto Bay National Park, Mexico Hidrobiológica, vol. 25, núm. 2, agosto, 2015, pp. 223-229 Universidad Autónoma Metropolitana Unidad Iztapalapa Distrito Federal, México Available in: http://www.redalyc.org/articulo.oa?id=57844304008 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative Hidrobiológica 2015, 25 (2): 223-229 Antibacterial and cytotoxic bioactivity of marine Actinobacteria from Loreto Bay National Park, Mexico Bioactividad antibacterial y citotóxica de actinobacterias marinas del Parque Nacional Bahía de Loreto, México Faviola Cardoso-Martínez1, Amayaly Becerril-Espinosa1, Celso Barrila-Ortíz1, Mónica Torres-Beltrán2, Héctor Ocampo-Alvarez3, Ana M. Iñiguez-Martínez1 and Irma E. Soria-Mercado1 1 Facultad de Ciencias Marinas, Universidad Autónoma de Baja California, km 103 Carretera Tijuana- Ensenada, Baja California, 22830, México 2 Department of Microbiology & Immunology, University of British Columbia, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver, BC, V6T 1Z3 Canada 3 Departamento de Hidrobiología, Universidad Autónoma Metropolitana Iztapalapa, Av. San Rafael Atlixco No. 186, Col. Vicentina, Iztapalapa, D.F. México 09340, México e-mail: [email protected] Cardoso-Martínez F., A. Becerril-Espinosa, C. Barrila-Ortíz, M. Torres-Beltrán, H. Ocampo-Álvarez, A.
    [Show full text]